MedPath

Home Ventilatory Support in Children

Active, not recruiting
Conditions
Sleep Apnea Syndromes in Children
Registration Number
NCT06172868
Lead Sponsor
Tampere University Hospital
Brief Summary

The study consist of children, who have used home ventilatory support during years 2010-2020 in Tampere University Hospital. The study will describe retrospectively different diagnoses and symptoms which will lead to home ventilatory support. We also study compliance to treatment and it's disanvantages. The prospective part of the study describes the quality of live of these children by using questionnaires (PedSQL).

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
94
Inclusion Criteria
  • ICD-10 Code for Sleep apnea diagnose G47.3 AND G47.3 diagnose found from pediatric electronic patient records between years 2010-2020 OR Patient name found from pediatric multidisciplinary home respiratory team's clinical list
Exclusion Criteria
  • Age over 16
  • Patient starting home ventilation after 31st December 2020 or treatment ending before 1st January 2010
  • patients with sleep apnea but without home respiratory support treatment
  • Only theophylline treatment
  • High-flow oxygen therapy
  • Age over 16 at treatment onset
  • Never started treatment
  • Treatment starting point and ending before year 2010

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patient demographics of patients from 0 up to 16 years old treated by a multidisciplinary home respiratory support-team during January 2010 to December 2020 in Tampere University Hospital, Finland2022-2023

Data included patient demographics

Number of patients with clinical characteristics2022-2023

Data included underlying medical conditions and medications. The circumstances for home respiratory support onset, frequency of follow-up, complications, operative interventions to treat sleep apnea before and during period with home respiratory support were collected. The type of respiratory support (device, mode, interface) was recorded.

Secondary Outcome Measures
NameTimeMethod
The duration of treatment2022-2023

The duration of treatment during January 2010 to December 2020 in Tampere University Hospital, Finland were collected.

Trial Locations

Locations (1)

Mervi Järvelä

🇫🇮

Ilmajoki, Finland

© Copyright 2025. All Rights Reserved by MedPath